vs
Side-by-side financial comparison of ASSURED GUARANTY LTD (AGO) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
ASSURED GUARANTY LTD is the larger business by last-quarter revenue ($277.0M vs $270.8M, roughly 1.0× HUTCHMED (China) Ltd). ASSURED GUARANTY LTD runs the higher net margin — 43.0% vs 0.7%, a 42.2% gap on every dollar of revenue. On growth, ASSURED GUARANTY LTD posted the faster year-over-year revenue change (77.6% vs -16.5%).
Assured Investment Management (AIM) was an institutional asset management firm with a heritage in credit strategies, managing approximately $15.2 billion as of its defunct status in July 2023. Secondaries Investors referred to AIM as "one of the world's most prominent hedge funds".
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
AGO vs HCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $277.0M | $270.8M |
| Net Profit | $119.0M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | 59.6% | -13.2% |
| Net Margin | 43.0% | 0.7% |
| Revenue YoY | 77.6% | -16.5% |
| Net Profit YoY | 561.1% | -83.6% |
| EPS (diluted) | $2.56 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $277.0M | $270.8M | ||
| Q3 25 | $207.0M | — | ||
| Q2 25 | $281.0M | $277.7M | ||
| Q1 25 | $345.0M | $324.5M | ||
| Q4 24 | $156.0M | — | ||
| Q3 24 | $269.0M | — | ||
| Q2 24 | $202.0M | $305.7M | ||
| Q1 24 | $245.0M | — |
| Q4 25 | $119.0M | $2.0M | ||
| Q3 25 | $105.0M | — | ||
| Q2 25 | $103.0M | $455.0M | ||
| Q1 25 | $176.0M | $11.9M | ||
| Q4 24 | $18.0M | — | ||
| Q3 24 | $171.0M | — | ||
| Q2 24 | $78.0M | $25.8M | ||
| Q1 24 | $109.0M | — |
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 41.1% | ||
| Q1 24 | — | — |
| Q4 25 | 59.6% | -13.2% | ||
| Q3 25 | 65.2% | — | ||
| Q2 25 | 47.3% | -1.3% | ||
| Q1 25 | 66.4% | -5.0% | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 81.8% | — | ||
| Q2 24 | 46.5% | -9.0% | ||
| Q1 24 | 58.8% | — |
| Q4 25 | 43.0% | 0.7% | ||
| Q3 25 | 50.7% | — | ||
| Q2 25 | 36.7% | 163.8% | ||
| Q1 25 | 51.0% | 3.7% | ||
| Q4 24 | 11.5% | — | ||
| Q3 24 | 63.6% | — | ||
| Q2 24 | 38.6% | 8.4% | ||
| Q1 24 | 44.5% | — |
| Q4 25 | $2.56 | $0.00 | ||
| Q3 25 | $2.18 | — | ||
| Q2 25 | $2.08 | $0.52 | ||
| Q1 25 | $3.44 | $0.01 | ||
| Q4 24 | $0.40 | — | ||
| Q3 24 | $3.17 | — | ||
| Q2 24 | $1.41 | $0.03 | ||
| Q1 24 | $1.89 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $903.0M | $1.4B |
| Total DebtLower is stronger | $1.7B | $93.2M |
| Stockholders' EquityBook value | $5.7B | $1.2B |
| Total Assets | $12.2B | $1.8B |
| Debt / EquityLower = less leverage | 0.30× | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $903.0M | $1.4B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $939.0M | $1.4B | ||
| Q1 25 | $1.2B | $836.1M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.7B | $802.5M | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $1.7B | $93.2M | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | $93.4M | ||
| Q1 25 | $1.7B | $82.8M | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.7B | $82.1M | ||
| Q1 24 | $1.7B | — |
| Q4 25 | $5.7B | $1.2B | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $5.6B | $1.2B | ||
| Q1 25 | $5.6B | $759.9M | ||
| Q4 24 | $5.5B | — | ||
| Q3 24 | $5.7B | — | ||
| Q2 24 | $5.5B | $740.1M | ||
| Q1 24 | $5.6B | — |
| Q4 25 | $12.2B | $1.8B | ||
| Q3 25 | $12.1B | — | ||
| Q2 25 | $12.1B | $1.8B | ||
| Q1 25 | $11.9B | $1.3B | ||
| Q4 24 | $11.9B | — | ||
| Q3 24 | $12.3B | — | ||
| Q2 24 | $12.1B | $1.3B | ||
| Q1 24 | $12.2B | — |
| Q4 25 | 0.30× | 0.08× | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.30× | 0.08× | ||
| Q1 25 | 0.30× | 0.11× | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 0.31× | 0.11× | ||
| Q1 24 | 0.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $259.0M | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | 2.18× | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $259.0M | $8.2M | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | $78.0M | $-72.9M | ||
| Q1 25 | $87.0M | $40.3M | ||
| Q4 24 | $47.0M | — | ||
| Q3 24 | $17.0M | — | ||
| Q2 24 | $58.0M | $-39.8M | ||
| Q1 24 | $-74.0M | — |
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | — |
| Q4 25 | 2.18× | 4.21× | ||
| Q3 25 | 0.52× | — | ||
| Q2 25 | 0.76× | -0.16× | ||
| Q1 25 | 0.49× | 3.38× | ||
| Q4 24 | 2.61× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.74× | -1.54× | ||
| Q1 24 | -0.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGO
| Insurance Segment | $226.0M | 82% |
| Other | $37.0M | 13% |
| Gain Loss On Investments Member1 | $8.0M | 3% |
| Non Credit Impairment Related Unrealized Fair Value Gains Losses On Credit Derivatives | $6.0M | 2% |
HCM
Segment breakdown not available.